查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1459783

荷尔蒙避孕市场（方法：口服避孕药、透皮贴片、注射避孕药、子宫内避孕药和阴道环）- 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Hormonal Contraceptive Market (Method: Oral Contraceptives, Transdermal Patches, Injectable Contraceptives, Intrauterine Contraceptives, and Vaginal Rings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 161 Pages | 商品交期: 2-10个工作天内

价格

荷尔蒙避孕市场 - 报告范围

TMR 关于全球荷尔蒙避孕药市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球荷尔蒙避孕药市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球荷尔蒙避孕药市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解荷尔蒙避孕药市场。

市场概况
2022年市场价​​值 218 亿美元
2031 年市场价值 338 亿美元
CAGR 5%

该报告深入研究了全球荷尔蒙避孕药市场的竞争格局。全球荷尔蒙避孕药市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球荷尔蒙避孕药市场参与者的属性。

表内容

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：荷尔蒙避孕市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年荷尔蒙避孕药市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 关键技术/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：荷尔蒙避孕药市场分析与预测：依方法

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依方法划分，2017-2031
    • 口服避孕药
    • 透皮贴剂
    • 注射避孕药
    • 子宫内避孕药
    • 阴道环
  • 市场吸引力分析：依方法

第 7 章：荷尔蒙避孕药市场分析与预测：依荷尔蒙分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依激素分类，2017-2031
    • 仅孕激素
    • 组合荷尔蒙
  • 市场吸引力分析：按激素

第 8 章：荷尔蒙避孕药市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2017-2031
    • 药局
    • 妇科/生育诊所
    • 电子商务
    • 其他的
  • 市场吸引力分析：按激素

第 9 章：荷尔蒙避孕药市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美荷尔蒙避孕药市场分析与预测

第 11 章：欧洲荷尔蒙避孕市场分析与预测

第 12 章：亚太地区荷尔蒙避孕市场分析与预测

第 13 章：拉丁美洲荷尔蒙避孕市场分析与预测

第 14 章：中东与非洲荷尔蒙避孕市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（按级别和规模公司）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • AbbVie, Inc.
    • Afaxys, Inc.
    • Bayer AG
    • Agile Therapeutics
    • Merck & Co., Inc.
    • Piramal Enterprises Ltd.
    • Pfizer Inc.
    • HLL Lifecare Limited
Product Code: TMRGL49380

Hormonal Contraceptive Market - Scope of Report

TMR's report on the global hormonal contraceptives market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global hormonal contraceptives market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hormonal contraceptives market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hormonal contraceptives market.

Market Snapshot
Market Value in 2022US$ 21.8 Bn
Market Value in 2031US$ 33.8 Bn
CAGR5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hormonal contraceptives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hormonal contraceptives market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hormonal contraceptives market.

The report delves into the competitive landscape of the global hormonal contraceptives market. Key players operating in the global hormonal contraceptives market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hormonal contraceptives market profiled in this report.

Key Questions Answered in Global hormonal contraceptives Market Report:

  • What is the sales/revenue generated by hormonal contraceptives across all regions during the forecast period?
  • What are the opportunities in the global hormonal contraceptives market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hormonal Contraceptive Market - Research Objectives and Research Approach

The comprehensive report on the global hormonal contraceptives market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hormonal contraceptives market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hormonal contraceptives market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Hormonal Contraceptive Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Hormonal Contraceptive Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Hormonal Contraceptive Market Analysis and Forecast, by Method

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Method, 2017-2031
    • 6.3.1. Oral Contraceptives
    • 6.3.2. Transdermal Patches
    • 6.3.3. Injectable Contraceptives
    • 6.3.4. Intrauterine Contraceptives
    • 6.3.5. Vaginal Rings
  • 6.4. Market Attractiveness Analysis, by Method

7. Hormonal Contraceptive Market Analysis and Forecast, by Hormones

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Hormones, 2017-2031
    • 7.3.1. Progestin Only
    • 7.3.2. Combined Hormones
  • 7.4. Market Attractiveness Analysis, by Hormones

8. Hormonal Contraceptive Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Drug Stores
    • 8.3.2. Gynecology/Fertility Clinics
    • 8.3.3. E-commerce
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Hormones

9. Hormonal Contraceptive Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Hormonal Contraceptive Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Method, 2017-2031
    • 10.3.1. Oral Contraceptives
    • 10.3.2. Transdermal Patches
    • 10.3.3. Injectable Contraceptives
    • 10.3.4. Intrauterine Contraceptives
    • 10.3.5. Vaginal Rings
  • 10.4. Market Value Forecast, by Hormones, 2017-2031
    • 10.4.1. Progestin Only
    • 10.4.2. Combined Hormones
  • 10.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.5.1. Drug Stores
    • 10.5.2. Gynecology/Fertility Clinics
    • 10.5.3. E-commerce
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Method
    • 10.7.2. By Hormones
    • 10.7.3. By Distribution Channel
    • 10.7.4. By Country

11. Europe Hormonal Contraceptive Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Method, 2017-2031
    • 11.3.1. Oral Contraceptives
    • 11.3.2. Transdermal Patches
    • 11.3.3. Injectable Contraceptives
    • 11.3.4. Intrauterine Contraceptives
    • 11.3.5. Vaginal Rings
  • 11.4. Market Value Forecast, by Hormones, 2017-2031
    • 11.4.1. Progestin Only
    • 11.4.2. Combined Hormones
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Drug Stores
    • 11.5.2. Gynecology/Fertility Clinics
    • 11.5.3. E-commerce
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Method
    • 11.7.2. By Hormones
    • 11.7.3. By Distribution Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Hormonal Contraceptive Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Method, 2017-2031
    • 12.3.1. Oral Contraceptives
    • 12.3.2. Transdermal Patches
    • 12.3.3. Injectable Contraceptives
    • 12.3.4. Intrauterine Contraceptives
    • 12.3.5. Vaginal Rings
  • 12.4. Market Value Forecast, by Hormones, 2017-2031
    • 12.4.1. Progestin Only
    • 12.4.2. Combined Hormones
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Drug Stores
    • 12.5.2. Gynecology/Fertility Clinics
    • 12.5.3. E-commerce
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Method,
    • 12.7.2. By Hormones
    • 12.7.3. By Distribution Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Hormonal Contraceptive Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Method, 2017-2031
    • 13.3.1. Oral Contraceptives
    • 13.3.2. Transdermal Patches
    • 13.3.3. Injectable Contraceptives
    • 13.3.4. Intrauterine Contraceptives
    • 13.3.5. Vaginal Rings
  • 13.4. Market Value Forecast, by Hormones, 2017-2031
    • 13.4.1. Progestin Only
    • 13.4.2. Combined Hormones
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Drug Stores
    • 13.5.2. Gynecology/Fertility Clinics
    • 13.5.3. E-commerce
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Method,
    • 13.7.2. By Hormones
    • 13.7.3. By Distribution Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Hormonal Contraceptive Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Method, 2017-2031
    • 14.3.1. Oral Contraceptives
    • 14.3.2. Transdermal Patches
    • 14.3.3. Injectable Contraceptives
    • 14.3.4. Intrauterine Contraceptives
    • 14.3.5. Vaginal Rings
  • 14.4. Market Value Forecast, by Hormones, 2017-2031
    • 14.4.1. Progestin Only
    • 14.4.2. Combined Hormones
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Drug Stores
    • 14.5.2. Gynecology/Fertility Clinics
    • 14.5.3. E-commerce
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Method,
    • 14.7.2. By Hormones
    • 14.7.3. By Distribution Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. AbbVie, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology, Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Afaxys, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology, Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bayer AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology, Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Agile Therapeutics
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology, Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Merck & Co., Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology, Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Piramal Enterprises Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology, Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Pfizer Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology, Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. HLL Lifecare Limited
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology, Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview

List of Tables

  • Table 01: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 02: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 03: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 07: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 08: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 11: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 12: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 15: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 16: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 19: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 20: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 23: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 24: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Hormonal Contraceptive Market Size (US$ Mn) and Distribution (%), by Region, 2017-2031
  • Figure 02: Hormonal Contraceptive Market Revenue (US$ Mn), by Method, 2022
  • Figure 03: Hormonal Contraceptive Market Value Share, by Method, 2022
  • Figure 04: Hormonal Contraceptive Market Revenue (US$ Mn), by Hormones, 2022
  • Figure 05: Hormonal Contraceptive Market Value Share, by Hormones, 2022
  • Figure 06: Hormonal Contraceptive Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 07: Hormonal Contraceptive Market Value Share, by Distribution Channel, 2022
  • Figure 08: Hormonal Contraceptive Market Value Share, by Region, 2022
  • Figure 09: Hormonal Contraceptive Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 10: Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 11: Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 12: Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 13: Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 14: Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 15: Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 16: Hormonal Contraceptive Market Value Share Analysis, by Region, 2017-2031
  • Figure 17: Hormonal Contraceptive Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 18: North America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Hormonal Contraceptive Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 20: North America Hormonal Contraceptive Market Value Share Analysis, by Country, 2017-2031
  • Figure 21: North America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 22: North America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 23: North America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 24: North America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 25: North America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 26:North America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 27: Europe Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 29: Europe Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 30: Europe Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 31: Europe Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 32: Europe Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 33: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 34: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 35: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 36: Asia Pacific Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 38: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 39: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 40: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 41: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 42: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 43: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 44: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 45: Latin America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 47: Latin America Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 48: Latin America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 49: Latin America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 50: Latin America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 51: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 52: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 53: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 54: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 56: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 57: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 58: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 59: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 60: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 61: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 62: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031